C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution ASYS Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed i3 Verticals IIIV Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment GPN Q1 2026 Earnings EPS Beats Estimates by 366 as Stock Edges Higher SYK Q1 2026 Earnings EPS Misses Expectations as Stock Edges Lower